2020 American Transplant Congress

Saturday, May 30, 2020

3:30pm-4:00pm

The Safety and Effectiveness and of Isoniazid Empirical Prophylaxis Compared to Screening Based Prophylaxis Post Lung Transplantation

G. B. Korayem¹, R. S. Almaghrabi², N. I. AlSuhaibani¹, G. S. AlSwailem¹, M. A. AlShammari¹, D. A. Aleissa³

Poster Session B: Lung: All Topics  •  Virtual

3:30pm-4:00pm

The Safety and Efficacy of 6-Month Steroid Reduction Strategy after Kidney Transplantation: A Prospective Cohort Study

J. Bang, C. Oh, S. Lee

Poster Session C: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Virtual

3:30pm-4:00pm

The Scenario of Delayed Graft Function in Brazil

T. V. Sandes-Freitas¹, M. Mazzali², R. Manfro³, H. Tedesco-Silva⁴, L. Andrade⁵, V. Garcia⁶, E. Davi-Neto⁷, R. Esmeraldo⁸, C. Oliveira⁹, E. Lasmar¹⁰, R. Madeira¹¹, G. Ferreira¹², G. Meira¹³, F. Cavalcanti¹⁴, A. Bignelli¹⁵, D. Carvalho¹⁶, D. Pedroso¹⁷, L. Deboni¹⁸, A. Silva e Filho¹⁹, A. Vicari³, M. Sousa², .. on behalf of 'DGF multicêntrico' group²⁰

Poster Session D: Non-Organ Specific: Organ Preservation/Ischemia Reperfusion Injury  •  Virtual

3:30pm-4:00pm

The State of Interventional Clinical Trials in Solid Organ Transplant: Insights from a Systematic Analysis of Clinicaltrials.gov

A. C. Swaminathan¹, J. Li¹, K. Chiswell¹, W. McManigle¹, I. O’Doherty², W. Fitzsimmons³, J. L. Todd¹, S. Tibbs⁴, S. M. Palmer¹

Poster Session C: Quality Assurance Process Improvement & Regulatory Issues  •  Virtual

3:30pm-4:00pm

The Strategy and Utility of Checkpoint Inhibitor Therapy in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation

L. Jeng, S. Hsu, A. Thorat

Poster Session A: Liver: Hepatocellular Carcinoma and Other Malignancies  •  Virtual

3:30pm-4:00pm

The Study of Continuous Renal Replacement Therapy Performing in Pre-Retrieval Management of Marginal Criteria Donor Lung: A Retrospective Control Study

J. Huang¹, X. Zheng², Z. Wang¹, M. Huang², J. Chen¹

Poster Session C: Lung: All Topics  •  Virtual

3:30pm-4:00pm

The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?

D. Yoeli¹, M. Adams¹, R. Choudhury¹, T. Nydam¹, J. Pomposelli¹, J. Goss², M. Wachs¹

Poster Session C: Liver: Living Donors and Partial Grafts  •  Virtual

3:30pm-4:00pm

The Therapeutic Potential of Human Liver-Derived Stem Cells Transplantation in Carbon Tetrachloride-Induced Rat Liver Cirrhotic Model

S. Lee¹, J. Lee², H. Park², Y. Kim², S. Lee¹

Poster Session D: Cellular Therapies, Tissue Engineering / Regenerative Medicine  •  Virtual

3:30pm-4:00pm

The Time is Now: Improving Waiting Times in Minority Populations

L. Mendez-Castaner, L. Preczewski, M. Muldoon, A. Harshman, M. Goble, G. Guerra

Poster Session C: Kidney Deceased Donor Allocation  •  Virtual

3:30pm-4:00pm

The Transcriptomic Analysis Revealed a Clear Deregulation of the C1QB Gene in Peripheral Blood Mononuclear Cells of Renal Transplant Patients with Chronic Antibody Mediated Rejection

G. Zaza¹, S. Granata¹, G. Santoro¹, C. Caletti¹, P. Pontrelli², F. Rascio³, M. Rossi¹, S. Andrighetto¹, G. Grandaliano⁴

Poster Session A: Biomarker Discovery and Immune Modulation  •  Virtual